Extract medical entities from this patient correction/clarification. Return JSON with this structure: {...

{
  "entities": [
    {
      "entity_type": "diagnosis",
      "entity_value": "lung cancer",
      "entity_status": "confirmed",
      "confidence": 0.99,
      "correction_note": "Patient corrected previous record stating prostate cancer; clarified actual diagnosis is lung cancer"
    },
    {
      "entity_type": "biomarker",
      "entity_value": "EGFR positive",
      "entity_status": "positive",
      "confidence": 0.99,
      "correction_note": "Patient explicitly stated EGFR positive status"
    }
  ]
}

---

Quick Context on Your Corrections:

Thank you for clarifying! These are important distinctions:

Lung Cancer Diagnosis: This changes your treatment approach significantly. According to the NCCN Guidelines for Patients: Metastatic Non-Small Cell Lung Cancer, lung cancer treatment depends heavily on specific biomarkers.

EGFR Positive Status: This is excellent news for treatment options. EGFR mutations (like exon 19 deletions or L858R mutations) typically respond very well to targeted therapy — specifically kinase inhibitors, which are oral medications you can take at home. These drugs work by blocking the specific protein signals that help your cancer cells grow.

Questions to Ask Your Oncologist:

1. Which specific EGFR mutation do I have (exon 19 deletion, L858R, or another)?
2. What targeted therapy do you recommend as my first treatment?
3. Are there clinical trials available for my specific EGFR mutation?
4. What side effects should I expect, and how are they managed?

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.